2023 annual financial data
Werewolf Therapeutics 2023 Revenue growth
Direct answer
Revenue growth was 21.6%.
Operating income was -40,503,000 USD and net income was -37,368,000 USD.
Operating cash flow was -32,612,000 USD.
Get free Werewolf Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 19,943,000 USD
- Operating income
- -40,503,000 USD
- Net income
- -37,368,000 USD
- Operating cash flow
- -32,612,000 USD